We have been informed that for operational reasons, Pfizer has terminated their relationship with Care Access. Pfizer plans to continue the study as planned using a different third-party vendor. They intend to keep all existing participants enrolled in the trial. We will update the community as we receive any further information.
If you have any questions or concerns, please contact Alison Warfel at [email protected] or 466-2974, ext. 7.